AUROBEVERINE Modified-release capsule, hard Ref.[7479] Active ingredients: Mebeverine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Milpharm Limited, Ares Block, Odyssey Business Park, West End Road, Ruislip HA4 6QD, United Kingdom

Therapeutic indications

Adults and children over 10 years.

For the symptomatic relief of irritable bowel syndrome.

Posology and method of administration

Posology

Adults and children over 10 years

One capsule of 200 mg twice daily; one in the morning and one in the evening.

There are no safety risks for continued use up to a period of 1 year. However, once the desired effect is achieved after several weeks, the dose can be gradually reduced.

If one or more doses are missed, the patient should continue with the next dose as prescribed; the missed dose(s) should not be taken in addition to the regular dose.

Paediatric Population

Aurobeverine MR is not recommended for use in children aged under 10 years as the safety and effectiveness has not been established in this group.

Special Population

No posology studies in elderly, renal and/or hepatic impaired patients have been performed. No specific risk for elderly, renal and/or hepatic impaired patients could be identified from available post-marketing data.

Method of administration

Aurobeverine MR should be swallowed with a sufficient amount of water (at least 100 ml water). They should not be chewed because the coating is intended to ensure a controlled release (see section 5.2).

Overdose

Theoretically CNS excitability may occur in cases of overdose. In cases where mebeverine was taken in overdose, symptoms were either absent or mild and usually rapidly reversible. Observed symptoms of overdose were of a neurological and cardiovascular nature.

No specific antidote is known and symptomatic treatment is recommended.

Gastric lavage should only be considered in case of multiple intoxication or if discovered within about one hour. Absorption reducing measures are not necessary.

Shelf life

For blister packs: 36 months.

For HDPE container packs: 24 months.

In use shelf life for HDPE container packs: 3 months.

Special precautions for storage

Blister Pack:

Do not store above 30°C. Do not refrigerate or freeze. Store in the original package in order to protect from moisture.

HDPE container pack:

Store below 25°C. Store in the original container in order to protect from light and moisture.

Nature and contents of container

Blister pack: PVC/PVdC – Aluminium blisters in cartons.

Pack sizes of blister: 30 and 60 capsules.

HDPE container pack: HDPE bottles fitted with round white screw type continuous thread cap.

Pack sizes of HDPE container: 250 capsules.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special requirements for disposal.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.